Synthesis and nicotinic activity of epiboxidine: An isoxazole analogue of epibatidine

European Journal of Pharmacology

Volumn 321, Issue 2, 1997, Pages 189-194

  Badio, Barbara ^a   Garraffo, H Martin ^a   Plummer, Carlton V ^a   Padgett, William L ^a   Daly, John W ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

ABT 418; Analgesia; Epibatidine; Epiboxidine; Nicotine receptor

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; EPIBATIDINE; NICOTINIC AGENT; NICOTINIC RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CELL STRAIN; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-ANXIETY AGENTS; CEREBRAL CORTEX; GANGLIA; ISOXAZOLES; KINETICS; MALE; MICE; NICOTINE; NICOTINIC AGONISTS; NOCICEPTORS; PC12 CELLS; PYRROLIDINES; RATS; RECEPTORS, NICOTINIC; TRITIUM;

EID: 0031053794     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00939-9     Document Type: Article

References (18)

1. Alkondon, M. and E.X. Albuquerque, 1995, Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current, J. Pharmacol. Exp. Ther. 274, 771.
2. Badio, B. and J.W. Daly, 1994, Epibatidine, a potent analgetic and nicotinic agonist, Mol. Pharmacol. 45, 563.
3. Badio, B., D. Shi, H.M. Garraffo and J.W. Daly, 1995, Antinociceptive effects of the alkaloid epibatidine: further studies on involvement of nicotinic receptors, Drug Dev. Res. 36, 46.
4. Briggs, C.A., M.L. Hughes, L.M. Monteggia, T. Giordano, D. Donnelly-Roberts and S.P. Arneric, 1995, Ganglionic nicotinic acetylcholine receptor activation by the novel agonist ABT 418, Drug Dev. Res. 34, 39.
5. Brioni, J.D., D.J.B. Kim, M.S. Brodie, M.W. Decker and S.P. Arneric, 1995, ABT 418: discriminative stimulus properties and effect on ventral tegmental cell activity, Psychopharmacology 119, 368.
6. Damaj, M.I. and B.R. Martin, 1996, Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice, Eur. J. Pharmacol. 300, 51.
7. Damaj, M.I., K.R. Creasy, A.D. Grove, J.A. Rosecrans and B.R. Martin, 1994, Pharmacological effects of epibatidine optical enantiomers, Brain Res. 664, 34.
8. Damaj, M.I., K.R. Creasy, S.P. Welch, J.A. Rosecrans, M.D. Aceto and B.R. Martin, 1995, Comparative pharmacology of nicotine and ABT 418, a new nicotinic agonist, Psychopharmacology 120, 483.
9. Decker, M.W., J.D. Brioni, A.W. Bannon and S.P. Arneric, 1995, Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics, Life Sci. 56, 545.
10. Eddy, N.B. and D. Leimbach, 1953, Synthetic analgesics. II. Dithienyl-, butenyl- and dithienylbutylamines, J. Pharmacol. Exp. Ther. 107, 385.
11. Elliott, R.L., H. Kopecka, N.-H. Lin, Y. He and D.S. Garvey, 1995, A short, efficient synthesis of the novel cholinergic channel activator, ABT 418, from L-proline, Synthesis 772.
12. Garvey, D.S., J.T. Wasicak, M.W. Decker, J.D. Brioni, M.J. Buckley, J.P. Sullivan, G.M. Carrera, M.W. Holladay, S.P. Arneric and M. Williams, 1994, Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities, J. Med. Chem. 37, 1055.
13. Gerzanich, V., X. Peng, F. Wang, G. Wells, R. Anand, S. Fletcher and J. Lindstrom, 1995, Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors, Mol. Pharmacol. 48, 774.
14. Holladay, M.W., S.A. Lebold and N.-H. Lin, 1995, Structure-activity relationships of nicotinic acetylcholine receptor agonists as potential treatments for dementia, Drug Dev. Res. 35, 191.
15. Spande, T.F., H.M. Garraffo, M.W. Edwards, H.J.C. Yeh, L. Pannell and J.W. Daly, 1992, Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadoran poison frog, J. Am. Chem. Soc. 114, 3475.
16. Sullivan, J.P., M.W. Decker, J.D. Brioni, D. Donnelly-Roberts, D.J. Anderson, A.W. Bannon, C.-H. Kang, P. Adams, M. Piattoni-Kaplan, M.J. Buckley, M. Gopalakrishnan, M. Williams and S.P. Arneric, 1994, (±)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors, J. Pharmacol. Exp. Ther. 271, 624.
17. Szántay, C., Z. Kardos-Balogh and C. Szántay Jr., 1996, Epibatidine, in: The Alkaloids, Vol. 46, ed. G.A. Cordell, p. 95.
18. Xu, R., G. Chu and D. Bai, 1996, Total synthesis of (±)-epibatidine, Tetrahedron Lett. 37, 1463.